Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP
Apollo Hospitals Enterprise — Q1 FY27 Earnings Presentation
36 slides from Apollo Hospitals Enterprise's earnings presentation, Aug 12, 2026
Slide 1: Regulation 30 disclosure cover letter to stock exchanges
.~ ~ 24 AFH)O"O APOLLO HOSPITALS ENTERPRISE LIMITED OSPITALS CIN : L&85110TN1979PLC008035 August 12, 2026 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, ‘G’ Block Mumbai - 400 00
Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q1 FY27
N Vi Apollo Hospitals Enterprise Limited Earnings Update Q1 FY27 7
Slide 3: Disclaimer
Disclaimer P/A The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation no
Slide 4: Content
b Content AL S Financial Performance Snapshot & Business Segment wise Update 4-8 @ Consolidated Financials 10 @ Healthcare Services 12-21 @ Diagnostics & Retail Health (AHLL) 23-25 @ Digital Health & Pharmacy Distribution (Apollo HealthCo) 27-31 @ Annexure 33-34 © 2026 Apollo Hospitals Enterprise Lt
Slide 5: Financial Performance Snapshot Q1FY27
A 'L Financial Performance Snapshot Q1FY27 <e) % \nenio) Revenue Growth | EBITDA(Post Ind AS) h Mersin i Srowt G th PAT Yovon Growth . 20% 4 Healthcare Services 35,670 LR 8,617 uzs & 4,803 S Offline PD* 26,287 T 2x 1,910 3% P o (] fi APD:- Pharmacy Distribution o T . Online A PD" & © 247 3,484 113% 1
Slide 6: Largest Pan India Hospital Chain
é Largest Pan India Hospital Chain P/ s Capacity Operational Census Beds' Census Beds 77 [ I?—| 11,147 If_l— 9,857 Overall Total EEE & Delhi: 6 Amritsar: 1 ® 9 \fi Noida: 1 Bilaspur: 1 Owned Hospitals 48 9,642 8,352 wig\ 4 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Jaipur: 1 v Y Managed Hospitals ¢6 806 806
Slide 7: AHLL: Retail Health
5 L AHLL: Retail Health a' /g Apollo Health & Lifestyle Ltd | Apollo T > _ Fertility and Cloudnine Out-of-Hospital care ~ to combine (subject to /?;?oquenility- - Outpatient Clinics o ca approval) to create - Diagnostics ~ one of India’s largest - Day Surgery centers . Maternity and Fertility « Sing
Slide 8: Apollo HealthCo: India's Largest Omni-channel Healthcare Platform
E 'L AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd . % Apollo 247 Apollo Telehealth* / o ammm— 0. \ Unmatched Size « Provides comprehensive remote healthcare Ba = a - 49 Mn.+ Registered Users — ~ 8 Lacs Daily services. 2 . Active Users @ ni Manish - - Offers specialized t
Slide 9: Clinical Updates and New Initiatives
A 'L Clinical Updates and New Initiatives <® % o Apollo Children’s Hospital, Chennai was recognised among the World’s Best Hospitals 2026 by Newsweek and Statista and received a Cll award for its quality improvement initiative in paediatric epilepsy care. o Apollo Hospitals signed an MoU with the eP
Slide 10: Consolidated Financials
I | © | | Consolidated Financials
Slide 11: Consolidated Financials Q1FY27
Consolidated Financials Q1FY27 @ x @mo) P/A 0 Overall Consolidated Revenue grew by 21% to X 70,435 mio. Total Revenues 35,670 4,995 29,770 70,435 Q EBITDA grew by 28% to ¥ 10,920 mio. EBITDA (Pre 24|7 Cost) 8,617 590 2,624 11,831 margin (%) 24.2% 11.8% 8.8% 16.8% 24/7 Operating Cost (811) (811) 0 Co
Slide 12: Healthcare Services
Healthcare Services 11
Slide 13: Healthcare Services Financials
Healthcare Services Financials © x R mio) P/A No of Hospitals 48 45 Q Healthcare Services Revenue grew by 22% in Q1FY27 . Overall Operating beds 8,352 8,030 4% Volume grew by 13%. Occupancy 70% 65% (Established Units Volume grew by 11%, price of 4% and Case IP Discharges 171,662 151,517 13% mix /pay
Slide 14: Inpatients Revenue Mix Q1FY27
A— 'L Inpatients Revenue Mix Q1FY27 IPS Transplts Paed PSU & Govt \ Cardio Nephro 9% Self Pay Obs&Gynac Gen Surg m Inpatient Inpatient Others Specialty Mix Payor Mix — Onco* 7% Internal Med Gastro [ Insurance -/ Ortho * Oncology includes Radiotherapy and Chemotherapy © 2026 Apollo Hospitals Enterpri
Slide 15: Healthcare Services: Expansion Plan
Healthcare Services: Expansion Plan Commissioned 5 new hospitals (~1,000 Census beds) Of the total 1,000 Census beds, excluding Gurgaon, Pune (Phase 1 & Phase 2) Asset Light,Green Field 380 beds have been operationalized, with the Sonarpur, Kolkata Asset Light,Green Field 270 220 %310 75 Gachibowli,
Slide 16: Healthcare Services: Operational Snapshot
'L Healthcare Services : Operational Snapshot @Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and NCR '4 @Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating ] Indore, Guwahati, Madurai, Trichy, Nellore,Vizag, Kakinada, Mysore, Nashik, Pune, Bilaspur, Rourk
Slide 17: Tamil Nadu Region
N Tamil Nadu Region P/ ‘ ; Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Chennai Tamil Nadu Region Q1FY27 Q1FY26 YoY Operating Beds 2,002 2,033 -1.5% Bed Occupancy Rate (%) 70% 62% Trichy Inpatient volume 42,244 37,522 12.6% Karur Inpatient ALOS (days) 3.03 3.06 11.1% M
Slide 18: AP, Telangana Region
5 AP, Telangana Region N Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q1FY27 Q1FY26 YoY Operating Beds 1,415 1,290 9.7% Bed Occupancy Rate (%) 67% 63% Kakinada Inpatient volume 29,038 23,271 24.8% Kariganagar Inpatient ALOS (days) 2.97 3.18 6.6% H
Slide 19: Karnataka Region
Karnataka Region N Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q1FY27 Q1FY26 YoY Operating Beds 831 776 7.1% Bed Occupancy Rate (%) 70% 69% Inpatient volume 18,637 16,953 9.9% Inpatient ALOS (days) 2.82 2.87 1.7% Total Net Revenue (X mio) 4,295 3,543 21.2% Avg revenue per In Patient 196,7
Slide 20: Eastern Region
Eastern Region P//} ‘ ; Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela of Guwahati Operating Beds Q1FY27 Eastern Region Q1FY26 YoY 1,931 1,836 5.2% Bed Occupancy Rate (%) 76% 71% Inpatient volume 37,368 33,317 12.2% Inpatient ALOS (days) 3.56 3.55 0.1% Kolkata Bilaspur To
Slide 21: Western Region
5 Western Region P//} Metro:- Mumbai; Non Metro:- Nashik, Ahmedabad and Pune Western Region Ahmedabad Q1FY27 Q1FY26 YoY Operating Beds 940 888 5.9% Bed Occupancy Rate (%) 58% 52% Inpatient volume 15,370 13,097 17.4% Nashik JQ — 0 Inpatient ALOS (days) 3.21 3.23 0.5% Pune” Total Net Revenue (X mio) 3
Slide 22: Northern Region
Northern Region P/ ) § Metro:- NCR; Non Metro:- Lucknow and Indore ‘4 Northern Region jfi,a > Q1FY27 Q1FY26 YoY W Operating Beds 1,233 1,207 2.2% ’ Lucknow Bed Occupancy Rate (%) 73% 70% Inpatient volume 29,005 27,357 6.0% Inpatient ALOS (days) 2.81 2.82 .0.4% Total Net Revenue (X mio) 6,146 5,290 16
Slide 23: Diagnostics & Retail Health
Diagnostics & Retail Health 22
Slide 24: Executive Summary
A_ 'L Executive Summary Primary Care Diagnostics = ) = S % S /A’;ollo Dia'fif,fi\_zfollo C|ini5_2|?°"° Sugal? _A’%)Ilom' ( /?jfi'ollo ® [ . ?f“““ .—\ Clinics A2 DIAGNOSTICS (" Afbiiospectrs a Efi’olloFertility Spedallsts In Surgery cspial » Core Primary Care revenue grew ~7% YoY in » Net addition of 2 H
Slide 25: AHLL Financials Q1FY27
AHLL Financials Q1FY 27 & mio) P//: Corporate / Primary Care Diagnostics Specialty Care Intra Group Revenue 1,266 2,003 1,927 -201 4,995 Q AHLL Revenue & EBITDA grew by 15% & EBITDA 245 281 214 -150 590 46% YoY in Q1 FY27 respectively; Q1FY27 * Primarily driven by 31% & 136% YoY EBIT 175 203 12 -162
Slide 26: Diagnostics: Key Parameters
_ Diagnostics : Key Parameters P/} <® [ Gross Revenue (INR Mn) EBITDA (INR Mn)! Operational footprint (as of June 30, 2026) ! +136% YoY 1,827 1,768 +31AYoY Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 m Gross Revenue (Rs. Mn) mmm EBITDA (Rs. Mn) ~—o—EBITDA Margin %
Slide 27: Digital Health & Pharmacy Distribution
Digital Health & Pharmacy Distribution 26
Slide 28: India's Largest Omni-Channel Healthcare Platform
India’s Largest Omni-Channel Healthcare Platform - Apollo 247 Digital Platform Apollo Pharmacy Platform 7,440 Stores & = a Omni Private ~49 Mn+ Registrations @ hi Manish - Added (Q n label / generics ® Chandigarh: 4 mix & BookApolio Doctor Appointment > Himachal Pradesh: 8 o—— Closed (Q1) “ - QrFY27
Slide 29: Apollo HealthCo Financials Q1 FY27
'L, Apollo HealthCo Financials Q1 FY27 <o) (% mio) x P/A @ Healthco (Q1'FY27 vs Q1’FY26) o Health Co Revenue growth @22% growth in Q1’ FY27 vs Q1" FY26 excluding closure of non profitable corporate partner (Offline PD @ 22%, and Online PD + Apollo 247 @ 24%) o PATincreased 78% to Rs. 1,017 Mn in Q1°
Slide 30: Apollo HealthCo: Composite Scheme approved by Shareholders
I Apollo HealthCo: Composite Scheme as approved by the Shareholders : 24™ June 2026 P/} O (] Undertaking below transactions sequentially, via a scheme of arrangement » Demerger of Omnichannel pharmacy distribution (OCP) and Apollo 24|7 digital platform (shares of SED AHEL in Apollo Healthco Ltd) & r
Slide 31: Composite scheme: Resultant Shareholding Structure
I Composite scheme: Resultant Shareholding Structure as approved by Shareholders 9/3 <o) 15% + 2.5%** AHEL . 00 Keimed promoters and Other SH . T Estimated Listing by AHEL 421% 25.5% Q4FY27 post all Shareholders Advent ESOP approvals. ( \I“' OD B OD Effective AHEL plus AHEL 12:1% 3.0% shareholders c
Slide 32: Combined Proforma Financial Metrics (Proposed New Co) Q1FY27
@—I Combined Proforma Financial Metrics (Proposed New Co) Q1FY27 Ps . Rmio) WAL Ql1’FY27 : - Comblned Comblned Offline Pharma online Pharma 4 - N E—E—— - Combined FY26 Q4’FY26 Distribution ¥ Distribution+247 ® TotalHealthco 4 Keimed g Q1’FY27 Revenue 1,90,366 49,865 26,287 3,484 29,770 41151 53,468
Slide 33: Annexure
Annexure 32
Slide 34: Basis of Consolidation
Basis of Consolidation P/} <o) AHEL AHEL Standalone Hospitals (100% Subsidiaries Location Description Ownership Ownership) Location Material Subs Chennai Main Chennai Apollo HealthCo Limited India Digital Omni-Channel Healthcare services Platform 99.68% ACI - Chennai Chennai Apollo Health and Lifest
Slide 35: IND AS 116: Impact on P&L and Balance Sheet Q1FY27
IND AS - 116 : Impact on P&L and Balance Sheet —Q1FY27 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset Revenue Right of use Asset Revenue as of Other expenses as of N 27,923 Other expenses ¥ 847 30 June,
Slide 36: Thank you
Thank you
Apollo Hospitals Enterprise — Q1 FY27 Earnings Presentation on 6ix